Well-known global Indian scientists and thought leaders Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech International Limited and Dr Sanjay Singh, CEO, Gennova Biopharmaceuticals will be elucidating about the journey of COVID vaccine development and some of the big moments of this period, changes and challenges that await us post pandemic.
The interactive panel titled Reimagining healthcare in a globalized world – Post COVID, will be moderated by Prof Rajib Dasgupta, Chairperson, Centre of Social Medicine and Community Health, Jawaharlal Nehru University (JNU) who will be posing on the development of India’s first indigenous COVID vaccine Covaxin and the intranasal vaccine BBV154. The journey and challenges faced in developing the country’s first mRNA COVID-19 vaccine HGCO19, which will be out by the end of the year, will be shared by Dr Sanjay Singh, CEO, Gennova Biopharmaceuticals. Dr Ella and Dr Singh will also be discussing the management of future pandemics.
The two-day Global Townhall virtual event brings in the global icons to identify and deliberate on the challenges and opportunities in a vast array of topics ranging from sustainability and the geo-political outlook to emerging business trends. The other top healthcare leaders who will be participating in the event will be R S Sharma, CEO, National Health Authority of India (NDHM, CoWin, AB PM-JAY) and Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group.
The other luminary global leaders include Pekk Lundmark, CEO, Nokia; Harsh Mariwala, Founder & Chairman, Marico; Jonas Kjellberg, Co Creator, Skype; Shiv Shivakumar, Group Executive President, Corporate Strategy & Business Development, Aditya Birla Group; Wolg-Henning Scheider, Chairman & CEO, ZF Friedrichshafen Group; Bhupesh Baghel, Chief Minister, Chhattisgarh; V C Sehgal, Chairman, Motherson Group; Subhash Kumar, Chairman and Managing Director, ONGC and Dr Rajendra Kumar (IAS), Additional Secretary, MeitY, Government of India, amongst others.